Correlation Between Kronos Bio and OmniAb

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and OmniAb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and OmniAb into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and OmniAb Inc, you can compare the effects of market volatilities on Kronos Bio and OmniAb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of OmniAb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and OmniAb.

Diversification Opportunities for Kronos Bio and OmniAb

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Kronos and OmniAb is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and OmniAb Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OmniAb Inc and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with OmniAb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OmniAb Inc has no effect on the direction of Kronos Bio i.e., Kronos Bio and OmniAb go up and down completely randomly.

Pair Corralation between Kronos Bio and OmniAb

Given the investment horizon of 90 days Kronos Bio is expected to generate 1.32 times more return on investment than OmniAb. However, Kronos Bio is 1.32 times more volatile than OmniAb Inc. It trades about 0.03 of its potential returns per unit of risk. OmniAb Inc is currently generating about -0.08 per unit of risk. If you would invest  95.00  in Kronos Bio on September 16, 2024 and sell it today you would earn a total of  3.00  from holding Kronos Bio or generate 3.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kronos Bio  vs.  OmniAb Inc

 Performance 
       Timeline  
Kronos Bio 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Kronos Bio may actually be approaching a critical reversion point that can send shares even higher in January 2025.
OmniAb Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OmniAb Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Kronos Bio and OmniAb Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kronos Bio and OmniAb

The main advantage of trading using opposite Kronos Bio and OmniAb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, OmniAb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OmniAb will offset losses from the drop in OmniAb's long position.
The idea behind Kronos Bio and OmniAb Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals